Lawmakers are heavily investing in pharmaceutical stocks despite ongoing threats from Trump to impose tariffs and enforce steep drug price cuts. Amanda Chu of POLITICO explains how these political pressures and potential policy changes are impacting the pharma industry, causing stock prices to rise. The video explores the reasons behind this trend, the implications for investors, and the complex relationship between government actions and the pharmaceutical market. Watch to understand why pharma stocks are soaring under these challenging circumstances.